Chemical inhibitors of Glycoprotein endo-alpha-1,2-mannosidase-like protein (MANEAL) encompass a range of compounds that indirectly target the glycoprotein processing pathways in which MANEAL is functionally involved. Swainsonine, an inhibitor of alpha-mannosidase II, can inhibit MANEAL by disrupting glycoprotein processing in the Golgi apparatus, a crucial area of MANEAL activity. Similarly, Kifunensine, as a mannosidase I inhibitor, impacts the initial steps of N-linked glycan processing, thereby potentially inhibiting MANEAL's role in this process. Deoxymannojirimycin and Deoxynojirimycin, both targeting alpha-mannosidase, could inhibit MANEAL by disrupting its role in the maturation of N-linked glycans, a key part of glycoprotein processing. Castanospermine, an inhibitor of beta-glucosidase, might indirectly inhibit MANEAL by affecting pathways involved in N-linked glycan modification, while 1-Deoxynojirimycin, another alpha-mannosidase inhibitor, could similarly disrupt MANEAL's function in processing N-linked glycans.
Additionally, Miglustat, by inhibiting glucosylceramide synthase, may alter glycolipid metabolism, indirectly impacting MANEAL's activity in glycoprotein processing. Alpha-glucosidase inhibitors such as Voglibose and Acarbose can inhibit MANEAL by affecting pathways involved in N-linked glycan maturation, a process integral to glycoprotein processing. Salbostatin, as a trehalase inhibitor, could also influence glycoprotein processing pathways, particularly those involving N-linked glycan modification, thereby inhibiting MANEAL. Pyrrolidine dithiocarbamate, an NF-kB inhibitor, might indirectly inhibit MANEAL by affecting signaling pathways that regulate glycoprotein processing. Brefeldin A, known for inhibiting protein transport from the endoplasmic reticulum to the Golgi, could disrupt essential pathways for MANEAL's function in glycoprotein processing. Each of these chemicals, through their impact on specific biochemical pathways or cellular processes, converges to potentially inhibit the functional role of MANEAL in glycoprotein processing, a critical aspect of cellular function.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Swainsonine | 72741-87-8 | sc-201362 sc-201362C sc-201362A sc-201362D sc-201362B | 1 mg 2 mg 5 mg 10 mg 25 mg | $135.00 $246.00 $619.00 $799.00 $1796.00 | 6 | |
Swainsonine, an inhibitor of alpha-mannosidase II, could inhibit MANEAL by disrupting glycoprotein processing in the Golgi apparatus, a pathway in which MANEAL is involved. | ||||||
Kifunensine | 109944-15-2 | sc-201364 sc-201364A sc-201364B sc-201364C | 1 mg 5 mg 10 mg 100 mg | $132.00 $529.00 $1005.00 $6125.00 | 25 | |
Kifunensine, a mannosidase I inhibitor, may inhibit MANEAL by affecting the initial steps of N-linked glycan processing, a process where MANEAL plays a role. | ||||||
Deoxymannojirimycin hydrochloride | 84444-90-6 | sc-201360 sc-201360A | 1 mg 5 mg | $93.00 $239.00 | 2 | |
Deoxymannojirimycin, targeting alpha-mannosidase, could inhibit MANEAL by disrupting its role in the processing and maturation of N-linked glycans. | ||||||
Castanospermine | 79831-76-8 | sc-201358 sc-201358A | 100 mg 500 mg | $180.00 $620.00 | 10 | |
Castanospermine, an inhibitor of beta-glucosidase, could indirectly inhibit MANEAL by affecting glycoprotein processing pathways, especially in N-linked glycan modification. | ||||||
Deoxynojirimycin | 19130-96-2 | sc-201369 sc-201369A | 1 mg 5 mg | $72.00 $142.00 | ||
1-Deoxynojirimycin, an alpha-mannosidase inhibitor, could disrupt MANEAL's function in the processing of N-linked glycans. | ||||||
Voglibose | 83480-29-9 | sc-204384 sc-204384A | 10 mg 50 mg | $194.00 $668.00 | ||
Voglibose, an alpha-glucosidase inhibitor, could inhibit MANEAL by impacting glycoprotein processing pathways, particularly those involving N-linked glycan maturation. | ||||||
Acarbose | 56180-94-0 | sc-203492 sc-203492A | 1 g 5 g | $222.00 $593.00 | 1 | |
Acarbose, another alpha-glucosidase inhibitor, might inhibit MANEAL by affecting glycoprotein processing and N-linked glycan modification. | ||||||
Pyrrolidinedithiocarbamic acid ammonium salt | 5108-96-3 | sc-203224 sc-203224A | 5 g 25 g | $32.00 $63.00 | 11 | |
Pyrrolidine dithiocarbamate, a NF-kB inhibitor, may indirectly inhibit MANEAL by affecting signaling pathways that regulate glycoprotein processing. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
Brefeldin A, inhibiting protein transport from the endoplasmic reticulum to the Golgi, could disrupt the pathway integral to MANEAL's function in glycoprotein processing. |